First report of an IMI-2 carbapenemase-producing Enterobacter asburiae clinical isolate in South Africa

Kwanele GquntaDepartment of Biochemistry and Microbiology, Nelson Mandela Metropolitan University, Port Elizabeth

, MSc(Microbiology), Student,

Johan van WykNational Health Laboratory Service, Port Elizabeth

, MBChB, MMed(ClinPath), Clinical Pathologist,

Pieter EkermansNational Health Laboratory Service, Port Elizabeth

, MBChB, MMed(ClinPath), Clinical Pathologist,

Colleen BamfordNational Health Laboratory Service (Groote Schuur Hospital) Division of Medical Microbiology, Department of Clinical Laboratory Sciences, University of Cape Town, Cape Town

, MBChB, FCPath, MMed(Path), Specialist (Microbiology),

Clinton MoodleyNational Health Laboratory Service (Groote Schuur Hospital) Division of Medical Microbiology, Department of Clinical Laboratory Sciences, University of Cape Town, Cape Town;Centre for Opportunistic, Tropical and Hospital Infections, National Institute of Communicable Diseases, Johannesburg

, PhD(Molecular and Cell Biology), Medical Scientist &

Sharlene GovenderDepartment of Biochemistry and Microbiology, Nelson Mandela Metropolitan University, Port ElizabethCorrespondence[email protected]

, PhD(Medical Microbiology), Microbiology Senior Lecturer

First report of an IMI-2 carbapenemase-producing Enterobacter asburiae clinical isolate in South Africa

Information for

Open access

Opportunities

Help and information

First report of an IMI-2 carbapenemase-producing Enterobacter asburiae clinical isolate in South Africa

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature